Protocol No.: A031704

Title
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer (PDIGREE)
Principal Investigator
Kamran, Amir
Phase
III
Age Group
Adult
Applicable Disease Site
Genitourinary Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sabrina Loudin, RN
Research Nurse
Phone: +1 304-293-6066

View on ClinicalTrials.gov